Search

everythinglearnresearchcommunity

for

Search:↓

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Clascoterone is a promising topical treatment for hair loss and acne with fewer side effects.

Ritlecitinib 50 mg effectively promotes and sustains hair regrowth in alopecia areata patients.

Cyproterone acetate with ethynyl estradiol significantly improved acne and seborrhea in women, but was less effective for hair loss and excessive hair growth.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

A baby with a rare metabolic disorder developed a rash not cured by zinc alone, likely due to both zinc and amino acid deficiencies.

Retinoids may help treat lupus nephritis and reduce steroid use.

Understanding acne medication chemistry helps doctors treat acne better.

Systemic retinoids do not increase COVID-19 risk or severity.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

Activin A helps heal skin wounds and protects the brain after injury.

JAK inhibitors show promise for treating various skin disorders effectively and safely.

Ritlecitinib helps reduce inflammation and promote hair regrowth in alopecia areata, especially in patchy-type cases.

Ritlecitinib may cause severe musculoskeletal pain in some alopecia universalis patients.

Cedrol promotes hair growth better than baricitinib by regulating immune cells.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

2.5 mg/mL TAC is as effective and safe as 5 mg/mL, but 5 mg/mL may improve hair regrowth and density more.

The gel with apocynin-loaded nanoparticles shows promise for treating rheumatoid arthritis.

DGAT1 enzyme is crucial for healthy skin and hair by regulating retinoid levels.

The document concludes that certain genetic mutations and dietary factors are involved in acne development, and treatments like isotretinoin and diet changes can help manage it.

Brepocitinib effectively reduces inflammation and improves symptoms in cicatricial alopecia with good safety.

Acne tarda is more common in women and those with darker skin, often linked to hormonal imbalances, and requires tailored treatment based on severity.

Various dermatologic treatments were effective for skin conditions like acne, rosacea, hair loss, and psoriasis from December 1986 to December 1987.

Oral isotretinoin was recommended for a 21-year-old woman with severe acne.

Aminoacridine and Abemaciclib, especially combined with Minoxidil, show promise for treating hair loss.